This is similar to humans where circulating IL-6 concentrations were reported to be higher in individuals with more severe disease and predicted hemodynamic changes in individuals with CHF, as indicated by left ventricular end-systolic volume, and contributions to systolic dysfunction have been noted in other human studies [48,49]. This evidence concerns the gene IL6 and congestive heart failure.